Navigation Links
Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
Date:10/28/2010

NEW YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The approach could also lead to new therapies for measles, mumps and the flu. The new research appears in today's edition of the prestigious journal Public Library of Science (PLoS) Pathogens.

The Nipah and Hendra viruses are members of the genus Henipavirus, a new class of virus in the Paramyxoviridae family, which includes the measles and the human parainfluenza virus (HPIV) that causes pediatric respiratory disease. The henipaviruses are carried by fruit bats (flying foxes) and are capable of causing illness and death in domestic animals and humans.

"These viruses are of great concern. The Hendra virus is highly fatal and is a considered a potential agent of bioterrorism. It currently poses a serious threat to livestock in Australia, where sporadic and deadly transmission to humans has occurred, with the potential for broader dissemination," says Dr. Matteo Porotto, the study's lead author and assistant professor of microbiology in pediatrics at Weill Cornell Medical College. "And the Nipah virus, which causes fatal encephalitis in up to 70 percent of human cases, causes seasonal outbreaks in Asia with person-to-person transmission now becoming a primary mode of infection. This virus could certainly cause global outbreaks."

Dr. Porotto and colleagues present a new strategy to prevent and treat these infections that may be broadly applicable for other "enveloped" viral pathogens, characterized by an outer wrapping that comes from the infected host cell. The new treatment was successfully tested in an animal model demonstrating central nervous system symptoms similar to those seen in humans.

Dr. Anne Moscona, professor of pediatrics and microbiology & immunology at Weill Cornell Medical College, vice chair of pediatrics for research at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, chief of pediatric infectious diseases and co-corresponding author of the paper, says, "It's crucial that we find treatments for the Nipah and Hendra viruses. In addition to acute infection, they can cause asymptomatic infection in as many as 60 percent of exposed people. They may also lead to late-onset disease or relapse of encephalitis years after initial infection, as well as persistent or delayed neurological problems."

According to Dr. Porotto, it is difficult to treat these pathogens because their "envelope" helps the virus survive and infect other cells. "We know that enveloped viruses must fuse their membrane with the target cell membrane in order to initiate infection, and blocking this step can prevent or treat infection, as has been clinically validated for the HIV virus."

Building on their past work, the team demonstrated in this study that the addition of a cholesterol group to HRC peptides that are active against Nipah virus dramatically increases their antiviral effect. The approach works by using the cholesterol-tagged peptides to target the membrane where the fusion occurs. There, the peptides interact with the fusion peptide before it inserts into the target cell membrane, disrupting the crucial membrane fusion process and preventing infection.

"The cholesterol-tagged HRC-derived peptides cross the blood-brain barrier and help prevent and treat the infection in animals for what would otherwise be fatal Nipah virus encephalitis," Dr. Porotto reports. "This suggests that they are promising candidates for the prevention or therapy of infection by Nipah and other lethal paramyxoviruses and may lead to better treatments for people affected by similar viruses including the measles, mumps and the flu."


'/>"/>

Contact: Andrek Klein
ank2017@med.cornell.edu
212-820-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. MRSA Strain With Outbreak Potential Among Reports at Disease Conference
2. Animal Study Explores Potential Gene Therapy for Depression
3. Adiponectin shows potential in blocking obesity-related carcinogenesis
4. Blocking an oncogene in liver cancer could be potential therapy option
5. Study details structure of potential target for HIV and cancer drugs
6. Study to investigate menstrual blood-derived stem cells as potential stroke therapy
7. Researchers identify potential new target for ovarian cancer
8. Toward safer plastics that lock in potentially harmful plasticizers
9. Purdue-IU team uncovers potential prostate cancer marker
10. A potential chemotherapeutic drug to treat hepatocellular carcinoma
11. Nutritions potential to save sight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... ... all of us, but there are things we can do to improve the odds of staying ... and more that there are simple, yet important steps that can be taken to maintain good ... recommends for her patients include;, , exercise , healthy ...
(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... ... 29, 2016 , ... The American workforce is on everyone’s ... Most importantly, employees are the single most important asset in creating value and ... , Just under half of American workers are emotionally checked out with low ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016 The ... USD 2.06 billion by 2022, according to a ... consumer awareness towards a healthy lifestyle is expected ... years.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... with rising health treatment expenditure has urged consumers ...
(Date:4/26/2016)... Mich. , April 26, 2016 Diplomat ... promotion of Jennifer Hagerman , Pharm D., to ... her growing role at Diplomat, Hagerman will continue to ... the company that delivers custom education and training to ... the specialty pharmacy industry. Diplomat University also houses the ...
(Date:4/26/2016)... , April 26, 2016 US demand ... to expand 4.9 percent annually to $27.6 billion ... healthcare facilities to decrease rates of healthcare-associated infections ... supplies, equipment, and services.  Although declining, the overall ... above targeted levels set by the CDC.  Recent ...
Breaking Medicine Technology: